Monopar Appoints Jeffrey D. Kent, M.D., as Executive Vice President, Head of Medical Affairs; Announces Two ALXN1840 Presentations at AASLD - The Liver Meeting® 2026 Life Science Investing
Cizzle Brands Corporation Announces Filing of Form F-10 Registration Statement with the U.S. Securities and Exchange Commission and Intention to List on a U.S. Exchange; Appoints Finance & Governance Veteran Dominic Scarangella to Board of Directors Biotech Investing
The Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo to Fight the Current Largest Ever and Expanding Ebola Outbreak to Begin Soon Life Science Investing
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors Life Science Investing
Entera Appoints Global Pharmaceutical Leader Riccardo Paolo Camisasca, M.D., as Chief Medical Officer Ahead of Planned EB613 Phase 3 Initiation Life Science Investing
AbbVie Announces 2026 AbbVie Immunology Scholarship Recipients, Celebrating 10 Years of Support Pharmaceutical Investing
PharmaTher Selects PD Labs, a National 503A Compounding Pharmacy, as the U.S. Center of Excellence for Its Personalized Medicine and Peptide Platform, PERSONALIZ3D Life Science Investing
Quantum-Si to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Life Science Investing
Alzamend Neuro's Phase 1/2A Lithium Imaging Data Accepted for Oral Presentation at ISMRM Workshop on X-Nuclei MR in Barcelona, Spain Life Science Investing
